-+ 0.00%
-+ 0.00%
-+ 0.00%

On July 21, Novo Nordisk filed a lawsuit against Eli Lilly in the US federal court, accusing Eli Lilly of misleading content in advertisements for its celebrity diet drug Zepbound and the hypoglycemic drug Mounjaro.

Zhitongcaijing·07/21/2026 11:49:05
Listen to the news
On July 21, Novo Nordisk filed a lawsuit against Eli Lilly in the US federal court, accusing Eli Lilly of misleading content in advertisements for its celebrity diet drug Zepbound and the hypoglycemic drug Mounjaro.